---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-001333"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:42:52.399497+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lipella raises $1.28M in registered direct offering of common stock and pre-funded warrants at $0.62/share

## Summary
- Total offering of 2,066,000 equity units (399K shares + 1,667K pre-funded warrants) at $0.62 per unit.
- Gross proceeds ~$1.28M closed August 1, 2024; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright served as exclusive placement agent; receives 7.5% cash fee and 154,950 warrants exercisable at $0.775.
- Pre-funded warrants exercisable immediately at $0.001/share with 9.99% beneficial ownership blocker.
- Company agreed to 30-day lock-up on equity issuance and 1-year restriction on variable rate transactions.

## SEC filing metadata
- accession: 0001753926-24-001333
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392624001333/0001753926-24-001333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392624001333/g084368_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-001333
- JSON: https://secwatch.observer/filing/0001753926-24-001333.json
- Plain text: https://secwatch.observer/filing/0001753926-24-001333.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.